| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |